Drugs that contain Acetaminophen; Ibuprofen
1. Combogesic patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10532036 | AFT PHARMS LTD | Combination composition |
Sep, 2025
(1 year, 11 months from now) | |
| US11197830 | AFT PHARMS LTD | Pharmaceutical composition containing acetaminophen and ibuprofen |
Feb, 2039
(15 years from now) | |
| US11534407 | AFT PHARMS LTD | Pharmaceutical compostion containing acetominophen and ibuprofen |
Feb, 2039
(15 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product (NP) | Mar 1, 2026 |
Market Authorisation Date: 01 March, 2023
Treatment: A method of treating mild to moderate acute pain in adults by administering 975-1000 mg of acetaminophen and 292.5-300 mg of ibuprofen in a single administration
Dosage: TABLET;ORAL
More Information on Dosage
COMBOGESIC family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic